文献速递眼底病与葡萄膜炎

双靶点实时PCR诊断眼内弓形虫感染

Dual-target, real-time PCR for the diagnosis of intraocular Toxoplasma gondii infections.
PubMed 文献 · Br J Ophthalmol · 2019-01-12

本研究评估单反应、内部对照的双靶点实时PCR(B1和Rep529)在眼内液样本中检测弓形虫DNA的分析性能与临床表现。对148份眼内液样本检测显示,与巢式常规B1 PCR的阳性符合率为97.2%,阴性符合率为99.1%。

要点

  • 双靶点实时PCR检测眼内液弓形虫与巢式B1 PCR一致性高。
  • B1和Rep529组分的95%检测下限分别为1.05和0.83速殖子/mL。
  • 双靶点设计可在一靶点变异时仍确保弓形虫检出。

核心结论

  • 双靶点实时PCR检测眼内弓形虫DNA与巢式常规B1 PCR一致性优异。

研究设计与样本

  • 研究在美国一家眼科参考中心进行,使用系列稀释的培养Z185株确定检测下限。
  • 采用双靶点实时PCR检测2010年1月至2015年12月收集的148份存档眼内液样本(132份玻璃体、16份房水)。

主要发现

  • 双靶点实时PCR的B1组分95%检测下限为1.05速殖子/mL,Rep529组分为0.83速殖子/mL。
  • 与巢式常规B1 PCR相比,阳性符合率为97.2%(n=35/36;95%CI 83.7%至99.9%)。
  • 阴性符合率为99.1%(n=111/112;95%CI 94.4%至100%)。

关键数值与推荐

  • 阳性符合率97.2%(n=35/36;95%CI 83.7%至99.9%)。
  • 阴性符合率99.1%(n=111/112;95%CI 94.4%至100%)。
  • B1组分检测下限1.05速殖子/mL,Rep529组分检测下限0.83速殖子/mL。

临床怎么用

  • 该双靶点实时PCR可用于眼内液弓形虫DNA检测,与巢式B1 PCR结果高度一致。
  • 双靶点设计可在一靶点区域变异时仍确保检出弓形虫。

局限性

  • 研究仅使用存档眼内液样本,未报告前瞻性临床验证。
  • 评估基于与美国一家参考中心样本的比较,未报告外部多中心验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Toxoplasma gondii is the most common infectious cause of posterior uveitis worldwide. Two multicopy targets (B1 and Rep529) are commonly used in T. gondii PCR assays, but studies evaluating these targets in ocular fluid samples are limited. Herein, we determine the analytical characteristics of a single-reaction, internally controlled, dual-target, real-time T. gondii PCR and evaluate the clinical performance of this assay in intraocular fluid samples obtained at a reference ophthalmologic centre in the USA. METHODS: Lower limits of detection for the B1 and Rep529 components of the dual-target assay were determined using serial dilutions of cultured T. gondii strain Z185. The dual-target assay was then used to test 148 archived intraocular samples (132 vitreous,16 aqueous humour) collected at the Francis I. Proctor Foundation between January 2010 and December 2015 for testing by a nested, conventional PCR targeting the B1 gene. RESULTS: The 95% lower limits of detection for the dual-target assay was determined to be 1.05 tachyzoites/mL for B1 and 0.83 tachyzoites/mL for Rep529. Using archived clinical intraocular specimens, the dual-target assay demonstrated 97.2% positive per cent agreement (n=35/36; 95% CI 83.7% to 99.9%) and 99.1% negative per cent agreement (n=111/112; 95% CI 94.4% to 100%) compared with the nested, conventional B1 PCR. CONCLUSION: This single-reaction, internally controlled, dual-target (B1, Rep529) real-time PCR for the detection of T. gondii DNA in intraocular specimens demonstrated excellent agreement with nested, conventional, B1 PCR. The dual-target design may ensure T. gondii detection when variation is present in one of two target regions.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Gomez CA, Sahoo MK, Kahn GY, et al. Dual-target, real-time PCR for the diagnosis of intraocular Toxoplasma gondii infections. Br J Ophthalmol. 2019. PMID: 30636207. doi:10.1136/bjophthalmol-2018-313064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。